Jack J. Mcgovern Email & Phone Number

San Francisco, California, Us

Unlearn is a on a mission to advance artificial intelligence to eliminate trial and error in medicine. Our current products help biopharma companies develop drugs more ethically and efficiently by leveraging generative machine learning models to reduce the number of patients required for placebo controls in clinical trials. We enable clinical trial sponsors to run RCTs that are up to twice as fast, require fewer participants, produce better evidence about therapeutic efficacy, and in which fewer participants need to be given placebos.

RAPIDAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients using clinically proven, data-driven technology. Our validated platform allows clinicians worldwide to improve patient care and outcomes everyday. Promoted from CFO to COO, current areas of responsibility include: - Sales/Marketing; Legal / Contracts / Customer Success / Product Development & Engineering - International Operations: Administrative oversight of offices in North America, Europe, and Australia encompassing vendor relationships, statutory audits and HR administration - Capital Formation: Secured $25M of European-based Private Equity (Series B) and PPP debt financings. Process included drafting Business and Strategic Plans, Financial Modeling and forecasting, and development of KPIs, Dashboards and Management Reporting packages. Completed acquisition of 'adjacent' technology platform. - System Implementations: Salesforce and migration from Quickbooks to NetSuite

NovaBay Pharmaceuticals (NYSE: NBY), Inc., is a newly commercial Pharma manufacturer which has grown revenues from $4M - ~ $20M over the past three years. The company develops and markets anti-infective products for the ophthalmology and urology markets. Direct reports include Sales, Finance, Accounting, Sales Ops, IT, HR and Administration.

Jacksonville, Florida, Us

Recruited by the Board of Directors of this SaaS-based provider of planning solutions for the Healthcare Industry to restructure the firm and prepare it for sale. Broad operating responsibility with direct reports including: Sales & Marketing; Engineering; Operations and Administration. - Capital Markets: Recapitalized Company providing liquidity to run business while re-organizing business units and streamlining operations. - Strategic Initiatives: Spearheaded complete re-write of Company's product platform - Authored three year Strategic Plan with resulting annual budgets, cash flow forecasts and SaaS metrics and KPIs - Mergers & Acquisitions: Championed the successful negotiation, structuring and sale of the company to a PE firm.

Northshore provides Interim CFO services with an emphasis on accounting systems and reporting, capitalization and structuring, and operational enhancements. Clients include venture-backed and middle market companies with a primary focus on SaaS technology, Healthcare, Telco, Digital Marketing and manufacturing. - Revenue Recognition and Accounting Expertise: SaaS Accounting; ASC 606, 985-605, BSP, FX, Consolidations and Transfer Pricing - International Operations: Established and ran offices in Europe, Australia, India and China encompassing vendor relationships, statutory audits and HR administration - Capital Formation: Secured over $75M of equity, venture debt, and lease financings. Process included drafting Business and Strategic Plans, Financial Modeling and forecasting, and development of KPIs, Dashboards and Management Reporting packages. - System Implementations: Led four 'cloud-based' ERP, GL package implementations, integrating with Salesforce and related software support packages.

Us

International provider of software / hardware providing mobile video to telco suppliers. - Raised a total of $50M in two separate rounds of Venture Financing - Oversaw operations domestically and in Australia, India and Europe - Initiated and completed (back) GAAP audits covering a period of six years.

Us

International Equipment manufacturer and service provider for the Pharma/Biotech industries

- $750M provider of Direct Marketing materials and services to consumers and business - Raised $200M of public debt and completed two acquisitions - Achieved 'Post-Merger' Integration savings of $45M per annum - Raised Series A and B round funds totaling $35M for on-line subsidiary

M & A advisory services: identification, structuring, and due diligence of middle market acquisitions.Completed over 15 transactions totaling in excess of $500M

$100M Middle market computer trading and leasing organization.- Implemented new ERP and outbound call management systems- Developed Working Capital and transactional lines of credit to fund both trading and leasing operations

New York, Ny, Us

Performed audits of Leasing, Oil & Gas, and Banking industry